德马科技(688360) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 reached ¥350,977,061.60, representing a 25.55% increase compared to ¥279,559,928.41 in the same period last year[3] - Net profit attributable to shareholders was ¥31,634,997.78, a 49.12% increase from ¥21,214,731.43 year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥30,236,337.19, reflecting a 63.78% increase from ¥18,461,626.37 in the previous year[3] - Basic earnings per share rose to ¥0.17, up 54.55% from ¥0.11 in the same quarter last year[3] - Total operating revenue for Q1 2025 reached CNY 350,977,061.60, a 25.5% increase from CNY 279,559,928.41 in Q1 2024[17] - Net profit for Q1 2025 was CNY 30,899,219.34, representing a 52.2% increase compared to CNY 20,349,235.39 in Q1 2024[18] - Earnings per share for Q1 2025 was CNY 0.17, compared to CNY 0.11 in Q1 2024[19] Assets and Liabilities - The company's total assets increased by 3.56% to ¥2,943,809,064.91 from ¥2,842,515,132.82 at the end of the previous year[4] - As of March 31, 2025, total assets amounted to RMB 2,943,809,064.91, an increase from RMB 2,842,515,132.82 as of December 31, 2024, reflecting a growth of approximately 3.55%[12] - Current assets totaled RMB 1,981,003,180.90, up from RMB 1,877,407,954.56, indicating an increase of about 5.52%[13] - The company's total liabilities increased to CNY 1,520,214,983.99 in 2025 from CNY 1,451,794,793.70 in 2024[15] - The company's total liabilities increased, with current liabilities rising significantly, indicating potential liquidity concerns[12] Cash Flow - The net cash flow from operating activities was negative at -¥120,857,478.15, compared to -¥56,391,635.72 in the previous year, indicating a significant cash flow challenge[3] - Cash inflow from operating activities in Q1 2025 totaled CNY 223,017,316.54, down from CNY 256,672,991.55 in Q1 2024[20] - The net cash flow from operating activities was -$120.86 million, compared to -$56.39 million in the previous period, indicating a decline in operational cash generation[21] - The company reported a total cash outflow from operating activities of $343.87 million, compared to $313.06 million in the previous period[21] Research and Development - Research and development expenses totaled ¥24,849,133.58, a 19.05% increase from ¥20,873,132.09 year-on-year[3] - Research and development expenses for Q1 2025 were CNY 24,849,133.58, an increase from CNY 20,873,132.09 in Q1 2024[17] - The proportion of R&D expenses to operating revenue decreased to 7.08%, down 0.39 percentage points from 7.47%[4] Shareholder Information - The company reported a total of 8,723 common shareholders at the end of the reporting period[9] - The company reported a total of 65,510,094 shares held by Huzhou Derma Investment Consulting Co., Ltd., representing the largest shareholder[10] Investment and Financing Activities - Cash inflow from investment activities totaled $115.57 million, a significant increase from $5.13 million in the prior period[21] - Cash inflow from financing activities amounted to $112.97 million, up from $75.12 million in the previous period[22] - The net cash flow from financing activities was $84.09 million, a substantial increase from $0.89 million in the prior period[22] Other Financial Metrics - The weighted average return on equity improved to 2.26%, an increase of 0.67 percentage points from 1.59%[3] - Cash and cash equivalents decreased to RMB 405,966,819.74 from RMB 490,435,250.65, representing a decline of approximately 17.25%[12] - Accounts receivable rose to RMB 608,064,971.46, compared to RMB 480,762,350.82, marking an increase of around 26.54%[12] - Inventory increased to RMB 528,024,084.19 from RMB 441,096,047.01, showing a growth of approximately 19.69%[13] - Short-term borrowings increased to RMB 75,684,380.69 from RMB 49,611,087.55, reflecting a rise of about 52.55%[13] - The company has a long-term investment of RMB 55,999,223.95, down from RMB 63,870,772.19, indicating a decrease of approximately 12.92%[13] - The company's long-term borrowings increased to CNY 294,078,914.51 in 2025 from CNY 232,745,459.79 in 2024[15] - The company paid $78.03 million in employee compensation, an increase from $72.85 million in the prior period[21] - The company recorded a cash outflow of $21.40 million for debt repayment, down from $67.20 million in the previous period[22] - The impact of exchange rate changes on cash and cash equivalents was a positive $269.63 thousand, contrasting with a negative impact of $725.00 thousand in the previous period[22] Strategic Focus - The company is focusing on expanding its market presence and enhancing its product offerings through new technology development and strategic partnerships[11]